Related Experiment Video
Updated: Jul 16, 2025

A High-Fidelity Porcine Model of Orthotopic Heart Transplantation Following Donation after Circulatory Death
Published on: June 6, 2025
Acute rejection in donation after circulatory death (DCD) heart transplants
Selena S Li1, Masaki Funamoto2, Asishana A Osho1
1Cardiac Surgery, Massachusetts General Hospital, Boston, Massachusetts.
Insights
Donation after circulatory death (DCD) heart transplants show similar early survival to donation after brain death (DBD) transplants, but DCD recipients face a higher risk of acute rejection. Further research is needed on long-term outcomes.
Area of Science:
- Cardiology
- Transplantation Medicine
- Immunology
Background:
- Donation after circulatory death (DCD) heart transplantation offers potential for increased organ availability.
- Early survival rates for DCD heart transplants are promising.
- The impact of DCD on acute rejection remains an area requiring further clarification.
Purpose of the Study:
- To compare the incidence of acute rejection in adult heart transplant recipients between DCD and DBD donors.
- To identify predictors of acute rejection in DCD versus DBD heart transplant recipients.
Main Methods:
- Analysis of the United Network for Organ Sharing database for adult heart transplants between December 2019 and December 2021.
- Exclusion of multiorgan transplants and patients lost to follow-up.
- Primary outcome: acute rejection, comparing DCD and donation after brain death (DBD) cohorts.
Main Results:
- DCD recipients (n=292) were less likely to require mechanical support (IABP, ECMO, LVAD) or be hospitalized pre-transplant compared to DBD recipients (n=5,582).
- DCD recipients demonstrated a higher likelihood of acute rejection before discharge (23.3% vs 18.4%) and hospitalization for rejection (23.4% vs 11.4%) at 15-month follow-up.
- DCD donation independently predicted acute rejection (OR 1.47) and hospitalization for rejection (OR 2.03), with higher rates observed in subgroup analyses.
Conclusions:
- DCD heart transplant recipients exhibit a significantly higher incidence of acute rejection compared to DBD recipients.
- While early survival is comparable, the increased early rejection in DCD recipients warrants further investigation into long-term implications.
- The findings suggest a need for optimized immunosuppression protocols or closer monitoring for DCD heart transplant recipients.
Background:
Donation after circulatory death (DCD) heart transplantation has promising early survival, but the effects on rejection remain unclear.
Methods:
The United Network for Organ Sharing database was queried for adult heart transplants from December 1, 2019, to December 31, 2021. Multiorgan transplants and loss to follow-up were excluded. The primary outcome was acute rejection, comparing DCD and donation after brain death (DBD) transplants.
Results:
A total of 292 DCD and 5,582 DBD transplants met study criteria. Most DCD transplants were transplanted at status 3-4 (61.0%) compared to 58.6% of DBD recipients at status 1-2. DCD recipients were less likely to be hospitalized at transplant (26.7% vs 58.3%, p < 0.001) and to require intra-aortic balloon pumping (IABP; 9.6% vs 28.9%, p < 0.001), extracorporeal membrane oxygenation (ECMO; 0.3% vs 5.9%, p < 0.001) or temporary left ventricular assist device (LVAD; 1.0% vs 2.7%, p < 0.001). DCD recipients were more likely to have acute rejection prior to discharge (23.3% vs 18.4%, p = 0.044) and to be hospitalized for rejection (23.4% vs 11.4%, p = 0.003) at a median follow-up of 15 months; the latter remained significant after propensity matching. On multivariable logistic regression, DCD donation was an independent predictor of acute rejection (odds ratio [OR] 1.47, 95% confidence interval [CI] 1.00-2.15, p = 0.048) and hospitalization for rejection (OR 2.03, 95% CI 1.06-3.70, p = 0.026). On center-specific subgroup analysis, DCD recipients continued to have higher rates of hospitalization for rejection (23.4% vs 13.8%, p = 0.043).
Conclusions:
DCD recipients are more likely to experience acute rejection. Early survival is similar between DCD and DBD recipients, but long-term implications of increased early rejection in DCD recipients require further investigation.
Related Concept Videos
Kidney Transplant I: Introduction
Kidney Transplant II: Surgical Procedure
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...

